BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11876710)

  • 1. Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test.
    Parente F; Sainaghi M; Sangaletti O; Imbesi V; Maconi G; Anderloni A; Bianchi Porro G
    Aliment Pharmacol Ther; 2002 Mar; 16(3):553-7. PubMed ID: 11876710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.
    Levine A; Shevah O; Shabat-Sehayek V; Aeed H; Boaz M; Moss SF; Niv Y; Avni Y; Shirin H
    Aliment Pharmacol Ther; 2004 Jul; 20(1):117-22. PubMed ID: 15225178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    Giannini E; Romagnoli P; Fasoli A; Chiarbonello B; Malfatti F; Botta F; Risso D; Lantieri PB; Savarino V; Testa R
    Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study.
    Cammarota G; Papa A; Cianci R; Cannizzaro O; Armuzzi A; Gasbarrini A; Addolorato G; Gasbarrini GB
    Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):247-50. PubMed ID: 10333196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test.
    Dulbecco P; Gambaro C; Bilardi C; Zentilin P; Mele MR; Mansi C; Biagini R; Tessieri L; Iiritano E; Usai P; Vigneri S; Savarino V
    Dig Dis Sci; 2003 Feb; 48(2):315-21. PubMed ID: 12643609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole.
    Andersson T; Holmberg J; Röhss K; Walan A
    Br J Clin Pharmacol; 1998 Apr; 45(4):369-75. PubMed ID: 9578184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantoprazole suppresses Helicobacter pylori without affecting cure.
    Adamek RJ; Szymanski C; Pfaffenbach B
    Helicobacter; 1999 Dec; 4(4):266-71. PubMed ID: 10597397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
    Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of proton pump inhibitors on the continuous real time (13)C-urea breath test.
    Shirin H; Frenkel D; Shevah O; Levine A; Bruck R; Moss SF; Niv Y; Avni Y
    Am J Gastroenterol; 2003 Jan; 98(1):46-50. PubMed ID: 12526935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Fujioka T; Kodama M; Kagawa J
    J Gastroenterol; 2003; 38(10):937-41. PubMed ID: 14614600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline.
    Dilger K; Zheng Z; Klotz U
    Br J Clin Pharmacol; 1999 Sep; 48(3):438-44. PubMed ID: 10510158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.
    Meyer UA
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S21-5. PubMed ID: 8930576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer.
    Labenz J; Tillenburg B; Weismüller J; Lütke A; Stolte M
    Aliment Pharmacol Ther; 1997 Feb; 11(1):95-100. PubMed ID: 9042979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.
    Bardhan KD; Dillon J; Axon AT; Cooper BT; Tildesley G; Wyatt JI; Gatz G; Braun W
    Aliment Pharmacol Ther; 2000 Jan; 14(1):59-67. PubMed ID: 10632646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
    Nakao M; Malfertheiner P
    Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients.
    Pazzi P; Scagliarini R; Gamberini S; Matarese V; Rizzo C; Gullini S
    Aliment Pharmacol Ther; 1998 Aug; 12(8):731-4. PubMed ID: 9726385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Knigge K; Fennerty MB
    Ann Intern Med; 1998 Oct; 129(7):547-50. PubMed ID: 9758575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
    Welage LS; Berardi RR
    J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial.
    Mulder CJ; Westerveld BD; Smit JM; Oudkerk Pool M; Otten MH; Tan TG; van Milligen de Wit AW; de Groot GH;
    Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):649-56. PubMed ID: 12072599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.